Access to Focal Spasticity Care: A Cross Canada Survey of Physiatrists.
Kevin E LiangPham Vivian NgoPaul WinstonPublished in: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques (2020)
Successful management of focal spasticity requires access to botulinum toxin type A (BoNT-A) injections, physiotherapy, occupational therapy, and orthoses/bracing. To assess the quality of focal spasticity care across Canada, we sent a survey consisting of 22 questions to physiatrists involved in the management of outpatient spasticity. Thirty-four physiatrists from all 10 provinces responded to the survey. Wait time for BoNT-A treatment averaged 12.7 weeks from time of referral across Canada. More than 75% of patients faced barriers to obtaining physical therapy and orthoses. Access to best quality care for spasticity patients across Canada varies widely.
Keyphrases
- botulinum toxin
- spinal cord injury
- end stage renal disease
- healthcare
- upper limb
- ejection fraction
- quality improvement
- palliative care
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- cerebral palsy
- primary care
- cross sectional
- children with cerebral palsy
- chronic pain
- smoking cessation
- replacement therapy
- patient reported